Please assess the completion status of the following clinical trial:

Trial Title: Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute Ward

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Aged 18 to 65 years, male or female~* In-patients suffering from schizophrenia according to DSM-IV diagnostic criteria with PANSS total score of greater than or equal to 60.~* Patients with PANSS-EC total score of greater than or equal to 14 and with at least one PANSS-EC symptom score greater than or equal to 4~Exclusion Criteria:~* Patients with history of seizure or with alcohol or substance abuse in the last 6 months~* Diabetes, Parkinson's disease or phaeochromocytoma~* Patients with hypertension and current use of antihypertensive agents~* Women who are pregnant, lactating or intend to become pregnant during the study period~* Poor response to two different antipsychotics in full dose and full course or use of clozapine previously~* Renal, hepatic, haematologic disease or other conditions may not suitable for the study based on investigator's evaluation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- 1. Zotepine (Type: EXPERIMENTAL): None
- 2. Risperidone (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).